Catalyst Event
The Cigna Group (CI) · Other
From KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index (KUSDV100P)
7/1/2026, 12:00:00 AM
President and COO Brian Evanko is scheduled to succeed David M. Cordani as Chief Executive Officer, effective July 1, 2026. This major leadership transition is estimated to have a high price impact of at least 10% due to significant changes in corporate governance scheduled.
Korean Translation
2026년 7월 1일부로 브라이언 에반코(Brian Evanko) 사장 겸 COO가 데이비드 코다니(David M. Cordani)의 뒤를 이어 CEO로 취임할 예정임. 주요 경영진 교체에 따른 지배구조 변화로 10% 이상의 높은 시장 영향이 예정됨.
Related Recent Events
Conocophillips (COP) · Earnings Release
As quarterly results typically drive price movements exceeding 10% for major energy producers, the Q2 2026 earnings release on 2026-08-06 is scheduled.
8/6/2026, 12:00:00 AM
EOG Resources Inc. (EOG) · Earnings Release
Q2 2026 earnings release is scheduled. This event is estimated to have a price impact of at least 1%.
8/6/2026, 12:00:00 AM
MetLife Inc (MET) · Earnings Release
MetLife is scheduled to release its Q2 2026 earnings results on August 5, 2026; a medium impact is expected as quarterly results are key performance indicators, scheduled.
8/5/2026, 12:00:00 AM
Cabot Corp (CBT) · Earnings Release
Q3 2026 earnings release scheduled. Analysts forecast an EPS of approximately $1.63 to $1.66 forecasted. Low importance estimated: historical price reaction to earnings is typically 1-5%.
8/3/2026, 12:00:00 AM
The Cigna Group (CI) · Earnings Release
Second quarter 2026 financial results are scheduled to be released. This recurring financial event is estimated to have a medium price impact of at least 5% based on historical volatility scheduled.
7/30/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Earnings Release
Q2 2026 earnings results are scheduled to be released on 2026-07-30. A market reaction of >1% is estimated upon the actual release scheduled.
7/30/2026, 12:00:00 AM